PROVISION OF LONG ACTING REVERSIBLE CONTRACEPTION (LARCS) IN PRIMARY CARE

The Midlands Partnership Foundation Trust has successfully completed a procurement process for the provision of Long Acting Reversible Contraception (LARCS) in primary care. This contract modification notice falls under the Health Care Services (Provider Selection Regime) Regulations 2023, meaning it is not subject to the Public Contracts Regulations 2015. The contract, with a total value of £1,837,086, was signed on 3rd June 2024.

The awarded contract covers services related to general-practitioner services (CPV: 85121100) and health services (CPV: 85100000) in the UKG2 region. The process did not require prior publication of a call for competition due to its regulatory framework. This tender provides significant opportunities for businesses specialising in healthcare services, particularly those with expertise in fitting and managing contraceptive implants and intrauterine devices.

Companies that can ensure adherence to current guidelines and best practices are well-positioned to benefit. The nature of the contract allows multiple providers to offer services, enhancing patient choice. Businesses with strong clinical and operational credentials that can meet stringent specifications are ideal contenders, potentially leveraging this contract to enhance their service portfolios and client reach within the healthcare sector.